NCT02078726View on ClinicalTrials.gov

Glucagon Use in Colonoscopies

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Colon Cancer
Interventions
DRUG

Glucagon

glucagon (hormone produced by the body) administered through IV

Trial Locations (1)

94117

San Francisco General Hospital, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02078726 - Glucagon Use in Colonoscopies | Biotech Hunter | Biotech Hunter